Allergic diseases in children with attention deficit hyperactivity disorder: A systematic review and meta-analysis

BMC Psychiatry

Volumn 17, Issue 1, 2017, Pages

  Miyazaki, Celine ^a   Koyama, Momoko ^b   Ota, Erika ^a,c   Swa, Toshiyuki ^a,d   Mlunde, Linda B ^b   Amiya, Rachel M ^b   Tachibana, Yoshiyuki ^a   Yamamoto Hanada, Kiwako ^a   Mori, Rintaro ^a  

^a NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c ST LUKE'S INTERNATIONAL UNIVERSITY   (Japan)

^d OSAKA UNIVERSITY   (Japan)

Author keywords

Allergic conjunctivitis; Allergic disease; Allergic rhinitis; Asthma; Atopic dermatitis; Attention deficit hyper disorder; Coexisting condition; Food allergy; Meta analysis

Indexed keywords

DOPAMINE 5 RECEPTOR; IMMUNOGLOBULIN E; METHYLPHENIDATE;

ALLERGIC CONJUNCTIVITIS; ALLERGIC DISEASE; ALLERGIC RHINITIS; ANXIETY DISORDER; ARTICLE; ASTHMA; ATOPIC DERMATITIS; ATTENTION DEFICIT DISORDER; AUTISM; CHILD PARENT RELATION; CLIMATE; COMORBIDITY; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA POLYMORPHISM; FOOD ALLERGY; GENETIC ASSOCIATION; HUMAN; IMMUNE RESPONSE; MAJOR DEPRESSION; MENTAL HEALTH; POLLUTION; PROTEIN EXPRESSION; SYSTEMATIC REVIEW; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CASE CONTROL STUDY; CHILD; CROSS-SECTIONAL STUDY; DERMATITIS, ATOPIC; FOOD HYPERSENSITIVITY; META ANALYSIS; RHINITIS, ALLERGIC;

ASTHMA; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CASE-CONTROL STUDIES; CHILD; CROSS-SECTIONAL STUDIES; DERMATITIS, ATOPIC; FOOD HYPERSENSITIVITY; HUMANS; RHINITIS, ALLERGIC;

EID: 85016468922     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/s12888-017-1281-7     Document Type: Article

References (46)

1. Marshall P. Attention deficit disorder and allergy: a neurochemical model of the relation between the illnesses. Psychol Bull. 1989;106(3):434-46.
2. Thomas R, Sanders S, Doust J, Beller E, Glasziou P. Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. Pediatrics. 2015;135(4):e994-1001.
3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders 5th ed. Washington: American Psychiatric Association Press; 2013.
4. August GJ, Realmuto GM, MacDonald III AW, Nugent SM, Crosby R. Prevalence of ADHD and comorbid disorders among elementary school children screened for disruptive behavior. J Abnorm Child Psychol. 1996;24(5):571-95.
5. Voeller KK. Attention-deficit hyperactivity disorder (ADHD). J Child Neurol. 2004;19(10):798-814.
6. Warshaw EM, Paller AS, Fowler JF, Zirwas MJ. Practical management of cutaneous reactions to the methylphenidate transdermal system: recommendations from a dermatology expert panel consensus meeting. Clin Ther. 2008;30(2):326-37.
7. Vashi NA, Souza A, Cohen N, Franklin B, Cohen DE. Allergic contact dermatitis caused by methylphenidate. Contact Dermatitis. 2011;65(3):183-5.
8. Wigal SB, McGough JJ, McCracken JT, Biederman J, Spencer TJ, Posner KL, Wigal TL, Kollins SH, Clark TM, Mays DA, et al. A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit/hyperactivity disorder. J Atten Disord. 2005;9(1):275-89.
9. Chang HY, Seo J-H, Kim HY, Kwon J-W, Kim B-J, Kim HB, Lee S-Y, Jang GC, Song DJ, Kim WK, et al. Allergic diseases in preschoolers are associated with psychological and behavioural problems. Allergy Asthma Immunol Res. 2013;5(5):315-21.
10. Comings DE, Gade-Andavolu R, Gonzalez N, Wu S, Muhleman D, Blake H, Chiu F, Wang E, Farwell K, Darakjy S, et al. Multivariate analysis of associations of 42 genes in ADHD, ODD and conduct disorder. Clin Genet. 2000;58(1):31-40.
11. Lee YH, Song GG. Meta-analysis of case-control and family-based associations between the 5-HTTLPR L/S polymorphism and susceptibility to ADHD. J Atten Disord. 2015
12. Merikangas KR, Calkins ME, Burstein M, He J-P, Chiavacci R, Lateef T, Ruparel K, Gur RC, Lehner T, Hakonarson H, et al. Comorbidity of physical and mental disorders in the neurodevelopmental genomics cohort study. Pediatrics. 2015;135(4):e927-38.
13. Petra AI, Panagiotidou S, Hatziagelaki E, Stewart JM, Conti P, Theoharides TC. Gut-microbiota-brain axis and its effect on neuropsychiatric disorders with suspected immune dysregulation. Clin Ther. 2015;37(5):984-95.
14. Miyazaki C, Koyama M, Ota E, Swa T, Amiya RM, Mlunde LB, Tachibana Y, Yamamoto-Hanada K, Mori R. Allergies in children with autism spectrum disorder: a systematic review and meta-analysis. Rev J Autism Dev Disord. 2015;2(4):374-401.
15. Hornig M. The role of microbes and autoimmunity in the pathogenesis of neuropsychiatric illness. Curr Opin Rheumatol. 2013;25(4):488-795.
16. Isgren A, Jakobsson J, Pålsson E, Ekman CJ, Johansson AG, Sellgren C, Blennow K, Zetterberg H, Landén M. Increased cerebrospinal fluid interleukin-8 in bipolar disorder patients associated with lithium and antipsychotic treatment. Brain Behav Immun. 2015;43:198-204.
17. Gillberg C, Gillberg IC, Rasmussen P, Kadesjö B, Söderström H, Råstam M, Johnson M, Rothenberger A, Niklasson L. Co-existing disorders in ADHD - implications for diagnosis and intervention. Eur Child Adolesc Psychiatry. 2004;13(Suppl 1):i80-92.
18. Subcommittee on Attention-Deficit/Hyperactivity Disorder, Steering Committee on Quality Improvement and Management, Wolraich M, Brown L, Brown RT, DuPaul G, Earls M, Feldman HM, Ganiats TG, Kaplanek B, et al. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics 2011; 128(5):1007-1022.
19. Schmitt J, Apfelbacher C, Chen C-M, Romanos M, Sausenthaler S, Koletzko S, Bauer C-P, Hoffmann U, Krämer U, Berdel D, et al. Infant-onset eczema in relation to mental health problems at age 10 years: results from a prospective birth cohort study (German Infant Nutrition Intervention plus). J Allergy Clin Immunol. 2010;125(2):404-10.
20. Schmitt J, Buske-Kirschbaum A, Roessner V. Is atopic disease a risk factor for attention-deficit/hyperactivity disorder? A systematic review. Allergy. 2010;65(12):1506-24.
21. Boris M, Goldblatt A. Pollen exposure as a cause for the deterioration of neurobehavioral function in children with autism and attention deficit hyperactive disorder: nasal pollen challenge. J Nutr Environ Med. 2004;14(1):47-54.
22. Biederman J, Milberger S, Faraone SV, Guite J, Warburton R. Associations between childhood asthma and ADHD: issues of psychiatric comorbidity and familiality. J Am Acad Child Adolesc Psychiatry. 1994;33(6):842-8.
23. Higgins J, Green S. Cochrane handbook for systematic reviews of interventions version 5.1. 0 [Updated 2011]. The Cochrane Collaboration:2011. http://handbook.cochrane.org. Accessed 15 December 2015
24. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Internal Med. 2009;151(4):264-9.
25. American Psychiatric Association. Diagnostic and statistical manual of mental disorders text-revision 4th ed. Washington: American Psychiatric Association Press; 2000.
26. National Institute for Health and Clinical Excellence. Attention deficit hyperactivity disorder: diagnosis and management. Clinical guideline[72]. London: NICE; 2016. https://www.nice.org.uk/guidance/cg72. Accessed 28 Mar 2016
27. Kim SY, Park JE, Lee YJ, Seo H-J, Sheen S-S, Hahn S, Jang B-H, Son H-J. Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity. J Clin Epidemiol. 2013;66(4):408-14.
28. Sterne JAC, Higgins JPT, Reeves BC, on behalf of the development group for ACROBAT-NRSI. A Cochrane risk of bias assessment tool: for non-randomized studies of interventions (ACROBAT-NRSI) version 1.0.0; 2014. http://methods.cochrane.org/news/risk-bias-assessment-tool-non-randomised-studies-interventions. Accessed 18 December 2015.
29. Review Manager (RevMan) [Computer program]. Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration; 2014.
30. GRADEpro GDT. GRADEpro Guideline Development Tool [Software]. (Developed by Evidence Prime, Inc.): McMaster University; 2015. http://www.gradepro.org. Accessed 3 Feb 2016.
31. Schünemann H, Brozek J, Guyatt GH, Oxman AD, editors. GRADE handbook for grading the quality of evidence and strength of recommendation using the GRADE approach [Updated October 2013]. The GRADE Working Group 2013. http://gdt.guidelinedevelopment.org/central_prod/_design/client/handbook/handbook.html. Accessed 18 Dec 2015.
32. Guyatt GH, Oxman AD, Sultan S, Glasziou P, Akl EA, Alonso-Coello P, Atkins D, Kunz R, Brozek J, Montori V, et al. GRADE guidelines: 9. Rating up the quality of evidence. J Clin Epidemiol. 2011;64(12):1311-6.
33. Chen M-H, Su T-P, Chen Y-S, Hsu J-W, Huang K-L, Chang W-H, Bai Y-M. Attention deficit hyperactivity disorder, tic disorder, and allergy: is there a link? A nationwide population-based study. J Child Psychol Psychiatry. 2013;54(5):545-51.
34. Hak E, de Vries TW, Hoekstra PJ, Jick SS. Association of childhood attention-deficit/hyperactivity disorder with atopic diseases and skin infections? A matched case-control study using the General Practice Research Database. Ann Allergy Asthma Immunol. 2013;111(2):102-6.
35. Suwan P, Akaramethathip D, Noipayak P. Association between allergic sensitization and attention deficit hyperactivity disorder (ADHD). Asian Pac J Allergy Immunol. 2011;29(1):57-65.
36. Kwon HJ, Lee MY, Ha M, Yoo SJ, Paik KC, Lim J-H, Sakong J, Lee C-G, Kang D-M, Hong SJ, et al. The associations between ADHD and asthma in Korean children. BMC Psychiatry. 2014;14:70.
37. Romanos M, Gerlach M, Warnke A, Schmitt J. Association of attention-deficit/hyperactivity disorder and atopic eczema modified by sleep disturbance in a large population-based sample. J Epidemiol Community Health. 2010;64(3):269-73.
38. Mill J, Curran S, Richards S, Taylor E, Asherson P. Polymorphisms in the dopamine D5 receptor (DRD5) gene and ADHD. Am J Med Genet B Neuropsychiatr Genet. 2004;125(1):38-42.
39. Ostadali MR, Ahangari G, Eslami MB, Razavi A, Zarrindast MR, Ahmadkhaniha HR, Boulhari J. The detection of dopamine gene receptors (DRD1-DRD5) expression on human peripheral blood lymphocytes by real time PCR. Iran J of Allergy Asthma Immunol. 2004;3(4):169-74.
40. Wu J, Xiao H, Sun H, Zou L, Zhu L-Q. Role of dopamine receptors in ADHD: a systematic meta-analysis. Mol Neurobiol. 2012;45(3):605-20.
41. Nakagome K, Imamura M, Okada H, Kawahata K, Inoue T, Hashimoto K, Harada H, Higashi T, Takagi R, Nakano K, et al. Dopamine D1-like receptor antagonist attenuates Th17-mediated immune response and ovalbumin antigen-induced neutrophilic airway inflammation. J Immunol. 2011;186(10):5975-82.
42. Bielory L. Allergic conjunctivitis and the impact of allergic rhinitis. Curr Allergy Asthma Rep. 2010;10(2):122-34.
43. Morar N, Willis-Owen SA, Moffatt MF, Cookson WO. The genetics of atopic dermatitis. J Allergy Clin Immunol. 2006;118(3):559.
44. Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, Goudie DR, Sandilands A, Campbell LE, Smith FJ, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet. 2006;38(4):441-6.
45. Johnston LK, Chien KB, Bryce PJ. The Immunology of Food Allergy. J Immunol. 2014;192(6):2529-34.
46. Gratten J, Wray NR, Keller MC, Visscher PM. Large-scale genomics unveils the genetic architecture of psychiatric disorders. Nat Neurosci. 2014;17(6):782-90.